TFS Capital’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-14,518
| Closed | -$46K | – | 449 |
|
|
2017
Q2 | $46K | Sell |
14,518
-1,686
| -10% | -$5.34K | 0.02% | 593 |
|
|
2017
Q1 | $55K | Sell |
16,204
-11,500
| -42% | -$39K | 0.02% | 622 |
|
|
2016
Q4 | $80K | Buy |
+27,704
| New | +$80K | 0.02% | 660 |
|
|
2016
Q3 | – | Sell |
-30,429
| Closed | -$91K | – | 1068 |
|
|
2016
Q2 | $91K | Buy |
+30,429
| New | +$91K | 0.02% | 869 |
|
|
2015
Q3 | – | Sell |
-76,364
| Closed | -$1.07M | – | 1099 |
|
|
2015
Q2 | $1.07M | Buy |
+76,364
| New | +$1.07M | 0.1% | 315 |
|
|
2014
Q4 | – | Sell |
-27,914
| Closed | -$355K | – | 1213 |
|
|
2014
Q3 | $355K | Buy |
27,914
+17,582
| +170% | +$224K | 0.03% | 700 |
|
|
2014
Q2 | $233K | Buy |
+10,332
| New | +$233K | 0.02% | 904 |
|